✦ LIBER ✦

Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes

✍ Scribed by Cabrera, S. M.; Colvin, S. C.; Tersey, S. A.; Maier, B.; Nadler, J. L.; Mirmira, R. G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucagon-like peptide 1 and inhibitors o

✍ Jens Juul Holst; Carolyn F Deacon 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Clinical and economical consequences of

✍ Sicras Mainar, A.; Roldán Suárez, C.; Font Ramos, B.; Navarro Artieda, R.; Ibáñe 📂 Article 📅 2013 🏛 Elsevier ⚖ 517 KB

Prevention and treatment of diabetes wit

✍ S.-M. Lee; H. Yang; D. M. Tartar; B. Gao; X. Luo; S. Q. Ye; H. Zaghouani; D. Fan 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 732 KB

Hormonal and metabolic effects of mornin

✍ Yan-Ling He; Jessica Valencia; Yiming Zhang; Sherwyn L. Schwartz; Monica Liguero 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 974 KB

Effect of initial combination therapy wi

✍ K. H. Yoon; G. R. Shockey; R. Teng; G. T. Golm; P. R. Thakkar; A. G. Meehan; D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Efficacy and safety of dipeptidyl peptid

✍ Wu, D.; Li, L.; Liu, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB